Published in Dis Colon Rectum on September 01, 1994
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
The treatment of giant periurethral condyloma in pregnancy using an ultrasonic thermal scalpel: a case report and new single session treatment option. Case Rep Obstet Gynecol (2015) 1.39
Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferon alfa therapy. Arch Dermatol (2000) 1.15
Malignancies of the anal margin and perianal skin. Clin Colon Rectal Surg (2009) 1.04
Anal cancer - a review. Int J Health Sci (Qassim) (2012) 1.01
The giant condyloma (buschke-löwenstein tumor) in the immunocompromised patient. Case Rep Obstet Gynecol (2014) 1.00
Reconstructive surgery in anal giant condyloma: Report of two cases. Int J Surg Case Rep (2013) 0.98
Verrucous carcinoma of the vulva: a case report. Case Rep Obstet Gynecol (2013) 0.97
Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. World J Surg Oncol (2013) 0.95
Buschke-Lowenstein tumour of glans penis. Int J Surg Case Rep (2014) 0.94
Verrucous carcinoma arising in an extended giant condyloma acuminatum (Buschke-Löwenstein tumor): a case report and review of the literature. J Med Case Rep (2013) 0.94
Magnetic resonance imaging of the vagina: an overview for radiologists with emphasis on clinical decision making. Radiol Bras (2015) 0.88
Perianal giant condyloma acuminatum-buschke-löwenstein tumor: a case report. Case Rep Surg (2012) 0.87
Buschke-Lowenstein tumor. J Dermatol Case Rep (2008) 0.84
Wide local excision for Buschke-Löwenstein tumor or circumferential carcinoma in situ. Tech Coloproctol (2011) 0.83
Diagnosis and management of premalignant penile lesions. Ther Adv Urol (2011) 0.83
Successful treatment of buschke-löwenstein tumour by surgical excision alone. J Cutan Aesthet Surg (2010) 0.81
Intra-abdominal localisation of a buschke-lowenstein tumour: case presentation and review of the literature. Case Rep Transplant (2013) 0.80
Giant anal condyloma (giant condyloma acuminatum of anus) after allogeneic bone marrow transplantation associated with human papillomavirus: a case report. J Med Case Rep (2015) 0.75
Perianal giant condyloma acuminata [buschke lowenstein tumour] - first case report from the Kashmir valley. Indian J Surg (2008) 0.75
A gigantic anogenital lesion: buschke-lowenstein tumor. Case Rep Dermatol Med (2014) 0.75
Giant anorectal condyloma acuminatum of buschke-lowenstein: successful plastic reconstruction with bilateral gluteal musculocutaneous v-y advancement flap. Indian J Surg (2012) 0.75
Buschke-Löwenstein Tumour: Successful Treatment with Minimally Invasive Techniques. Case Rep Dermatol Med (2015) 0.75
Giant condylomata acuminata of Buschke and Lowenstein: A peristomal variant. Int J Surg Case Rep (2014) 0.75
Rectal Involvement of Recurrent Buschke-Lowenstein Tumor Causing Subileus: a Case Report. Gastroenterology Res (2011) 0.75
Coexistence of Condylomata Acuminata with Warty Squamous Cell Carcinoma and Squamous Cell Carcinoma. Med Arch (2017) 0.75
Successful Surgical Management of Giant Condyloma Acuminatum (Buschke Lowenstein Tumor) in the Urethra of a Female Patient: A Case Report. Curr Urol (2015) 0.75
Buschke - Loewenstein tumor resection with simultaneous reconstruction of extensive tissue losses: case report. BMC Surg (2015) 0.75
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Hepatocellular carcinoma. Polygonal cell type with fibrous stroma--an atypical variant with a favorable prognosis. Cancer (1980) 1.99
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Metastatic patterns in soft-tissue sarcomas. Arch Surg (1983) 1.66
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology (1992) 1.58
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Xanthogranulomatous salpingitis and oophoritis: a case report and review of the literature. Arch Pathol Lab Med (2001) 1.23
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20
Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg (2000) 1.20
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Pancreatic carcinoma in perspective. A continuing challenge. Cancer (1996) 1.18
Squamous-cell carcinoma of the colon and rectum. Dis Colon Rectum (1983) 1.18
Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16
Patient selection for hepatic resection of colorectal metastases. Arch Surg (1996) 1.13
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Pelvic resection of recurrent rectal cancer. Ann Surg (1994) 1.08
Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07
Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery (1996) 1.07
Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05
Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00
Pleural mesothelioma. Cancer (1976) 0.99
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97
The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet (1975) 0.96
Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg (1984) 0.96
Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am (1996) 0.96
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer (1980) 0.95
Variants of hemipelvectomy. Am J Surg (1983) 0.95
Rectal injuries. J Trauma (1969) 0.94
Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer (1993) 0.93
Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg (1975) 0.93
Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol (2000) 0.92
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer (1981) 0.92
Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer (1977) 0.91
Immunologic reactivity and prognosis in breast cancer. Cancer (1980) 0.91
Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer (1986) 0.91
The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg (1997) 0.91
Colonoscopy: an essential monitoring technique after resection of colorectal cancer. Am J Surg (1983) 0.91
Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg (1992) 0.90
Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg (1995) 0.90
Mesenchymal chondrosarcoma of the kidney. Cancer (1984) 0.90
Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer (1985) 0.90
Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope (1985) 0.89
Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol (1998) 0.89
Carcinoma of the gallbladder. J Surg Oncol Suppl (1993) 0.89
Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique. Ann Surg Oncol (1996) 0.89
Prognostic analysis of survival in small breast cancers. J Am Coll Surg (1998) 0.88
Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum. Cancer (1981) 0.87
Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys (2000) 0.87
Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. Arch Surg (1986) 0.87
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma. Ann N Y Acad Sci (1976) 0.86
Extraorbital sebaceous carcinoma. Arch Surg (1985) 0.86
Colorectal cancer. A blueprint for disease control through screening by primary care physicians. Arch Surg (1986) 0.85
Characterization of two metastatic subpopulations originating from a single human colon carcinoma. Cancer Res (1983) 0.85
Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis. Arch Intern Med (1969) 0.85
Aortic valve replacement: a 9-year experience. Ann Thorac Surg (1980) 0.84
Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol (1997) 0.84
Ectopic bone in multinodular goiter. R I Med J (1989) 0.84
Reconstruction of full thickness chest wall defects. Ann Surg (1988) 0.84
Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology (1989) 0.83
Solitary cervical node metastasis in renal cell carcinoma. R I Med J (1990) 0.83
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest (2001) 0.83
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol (1997) 0.83
Cancer of the bile duct: the occult malignancy. Am J Surg (1975) 0.83
Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet (1988) 0.82
Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol (1996) 0.82
Catheter tract seeding after percutaneous biliary drainage for pancreatic cancer. Cancer (1986) 0.82
Primary gastric lymphoma. Problems in staging and management. Am J Surg (1988) 0.82
Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol (1985) 0.82
Treatment of gallbladder cancer. Cancer Treat Res (1994) 0.82
Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet (1977) 0.82